When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARDS - Aridis falls ~20% day after surging following COVID antibody cocktail data
Aridis Pharmaceuticals Inc.
CIPhotos/iStock via Getty Images Shares of Aridis Pharmaceuticals ([[ARDS]] -18.5%) are down sharply in afternoon trading, a day after shares surged following the release of encouraging preclinical data for its COVID-19 antibody cocktail. In an animal model, AR-712 was effective in neutralizing the delta variant of the virus. Aridis' most advanced candidate, AR-301, is a monoclonal antibody in phase 3 for bacterial pneumonia.